Skip to main content
News Icon

Europe is a top destination for many researchers

ImmunoSensation2 Scientist, Dr. Bernardo Franklin was feature in a Nature article entitled "Europe is a top destination for many researchers". The article interviewed scientists from different parts of the world who are working in the EU.

“Science is not a recognized profession in Brazil, where I come from,” says Bernardo Franklin, an immunologist at the University of Bonn in Germany. “In Germany, PhD students are given working contracts, with regulations that provide them with insurances, pension and other benefits, and protect them from exploitation and abusive supervisors.”

Publication

https://www.nature.com/articles/d41586-019-01570-3

Related news

Prof. Dr. Kaan Boztug

News categories: Honors & Funding

Kaan Boztug awarded Novartis Prize

Prof. Dr. Kaan Boztug from the University Hospital Bonn (UKB) receives the Novartis Prize for Therapy-Relevant Immunological Research 2025. The expert in rare diseases of the immune system and blood formation conducted most of the research work that has now been honored in Vienna. His work was supported by an ERC Starting Grant (ImmunoCore, 2012-2018) and an ERC Consolidator Grant (iDysChart, 2019-2025), among others. The science prize, worth 10,000 € is divided into two parts this time and also goes to Prof. Dr. Evelyn Ullrich.
View entry
Gunther Hartmann and Christina Wuebben

News categories: Focus

An RNA key against viruses

Activating the body's antiviral defense system: A novel RIG-I ligand developed at the Medical Faculty of the University of Bonn and the University Hospital Bonn (UKB) helps the body to recognize and fight off certain viruses at an early stage. This molecular structure has potential for the prevention and treatment of viral infections. Based on the research results, there are now plans to develop and market an antiviral nasal spray to protect against viral respiratory infections.
View entry
members of the Bonn-Cumming Host-Directed Pandemic Therapeutics Program

News categories: Focus

Joining forces against future pandemics

Three days of scientific exchange, workshops, and new impulses: Until July 2, 2025, members of the Bonn-Cumming Host-Directed Pandemic Therapeutics Program are gathered at University Hospital Bonn (UKB) for a symposium to reflect on the current state of their research and discuss further steps. The joint program of the Cumming Global Centre for Pandemic Therapeutics at the University of Melbourne and of the University of Bonn aims to combat future pandemics with novel therapeutics.
View entry

Back to the news overview